STERIS EPS - Earnings per Share 2010-2025 | STE
STERIS annual and quarterly earnings per share history from 2010 to 2025. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- STERIS EPS for the quarter ending March 31, 2025 was $1.48, a 7500% decline year-over-year.
- STERIS EPS for the twelve months ending March 31, 2025 was $6.20, a 62.73% increase year-over-year.
- STERIS 2025 annual EPS was $6.2, a 62.73% increase from 2024.
- STERIS 2024 annual EPS was $3.81, a 256.07% increase from 2023.
- STERIS 2023 annual EPS was $1.07, a 56.85% decline from 2022.
| STERIS Annual EPS | |
|---|---|
| 2025 | $6.20 |
| 2024 | $3.81 |
| 2023 | $1.07 |
| 2022 | $2.48 |
| 2021 | $4.63 |
| 2020 | $4.76 |
| 2019 | $3.55 |
| 2018 | $3.39 |
| 2017 | $1.28 |
| 2016 | $1.56 |
| 2015 | $2.25 |
| 2014 | $2.17 |
| 2013 | $2.72 |
| 2012 | $2.31 |
| 2011 | $0.85 |
| 2010 | $2.16 |
| 2009 | $1.86 |
| STERIS Quarterly EPS | |
|---|---|
| 2025-03-31 | $1.48 |
| 2024-12-31 | $1.75 |
| 2024-09-30 | $1.51 |
| 2024-06-30 | $1.46 |
| 2024-03-31 | $-0.02 |
| 2023-12-31 | $1.42 |
| 2023-09-30 | $1.16 |
| 2023-06-30 | $1.25 |
| 2023-03-31 | $1.88 |
| 2022-12-31 | $1.24 |
| 2022-09-30 | $-3.15 |
| 2022-06-30 | $1.10 |
| 2022-03-31 | $0.61 |
| 2021-12-31 | $1.42 |
| 2021-09-30 | $0.69 |
| 2021-06-30 | $-0.24 |
| 2021-03-31 | $1.02 |
| 2020-12-31 | $1.33 |
| 2020-09-30 | $1.23 |
| 2020-06-30 | $1.05 |
| 2020-03-31 | $1.43 |
| 2019-12-31 | $1.23 |
| 2019-09-30 | $1.11 |
| 2019-06-30 | $0.99 |
| 2019-03-31 | $1.26 |
| 2018-12-31 | $0.56 |
| 2018-09-30 | $0.91 |
| 2018-06-30 | $0.82 |
| 2018-03-31 | $0.85 |
| 2017-12-31 | $1.11 |
| 2017-09-30 | $0.75 |
| 2017-06-30 | $0.68 |
| 2017-03-31 | $0.31 |
| 2016-12-31 | $-0.06 |
| 2016-09-30 | $0.47 |
| 2016-06-30 | $0.56 |
| 2016-03-31 | $0.76 |
| 2015-12-31 | $0.26 |
| 2015-09-30 | $0.14 |
| 2015-06-30 | $0.40 |
| 2015-03-31 | $0.69 |
| 2014-12-31 | $0.63 |
| 2014-09-30 | $0.52 |
| 2014-06-30 | $0.41 |
| 2014-03-31 | $0.65 |
| 2013-12-31 | $0.48 |
| 2013-09-30 | $0.50 |
| 2013-06-30 | $0.54 |
| 2013-03-31 | $0.70 |
| 2012-12-31 | $0.82 |
| 2012-09-30 | $0.68 |
| 2012-06-30 | $0.52 |
| 2012-03-31 | $0.75 |
| 2011-12-31 | $0.58 |
| 2011-09-30 | $0.50 |
| 2011-06-30 | $0.48 |
| 2011-03-31 | $0.66 |
| 2010-12-31 | $0.36 |
| 2010-09-30 | $0.59 |
| 2010-06-30 | $-0.76 |
| 2010-03-31 | $0.50 |
| 2009-12-31 | $0.69 |
| 2009-09-30 | $0.54 |
| 2009-06-30 | $0.43 |
| 2009-03-31 | $0.47 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $22.465B | $5.460B |
| STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $182.012B | 22.03 |
| Intuitive Surgical (ISRG) | United States | $178.116B | 73.83 |
| Edwards Lifesciences (EW) | United States | $47.204B | 31.31 |
| IDEXX Laboratories (IDXX) | United States | $46.087B | 52.96 |
| Alcon (ALC) | Switzerland | $45.102B | 30.48 |
| DexCom (DXCM) | United States | $35.035B | 54.15 |
| IQVIA Holdings (IQV) | United States | $33.074B | 18.69 |
| Mettler-Toledo (MTD) | United States | $26.313B | 31.29 |
| Waters (WAT) | United States | $18.043B | 25.46 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.167B | 0.00 |
| Hologic (HOLX) | United States | $14.717B | 15.99 |
| Sysmex ADR (SSMXY) | Japan | $10.575B | 30.00 |
| Penumbra (PEN) | United States | $8.797B | 64.71 |
| Masimo (MASI) | United States | $8.618B | 31.79 |
| Globus Medical (GMED) | United States | $7.316B | 17.43 |
| Glaukos (GKOS) | United States | $5.358B | 0.00 |
| Teleflex (TFX) | United States | $5.103B | 8.42 |
| Integer Holdings (ITGR) | United States | $3.826B | 19.09 |
| TransMedics (TMDX) | United States | $3.546B | 77.08 |
| PROCEPT BioRobotics (PRCT) | United States | $2.979B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.399B | 14.28 |
| Nihon Kohden (NHNKY) | Japan | $2.020B | 23.17 |
| Elekta AB (EKTAY) | Sweden | $1.937B | 17.41 |
| Veracyte (VCYT) | United States | $1.916B | 26.89 |
| Alphatec Holdings (ATEC) | United States | $1.590B | 0.00 |
| Artivion (AORT) | United States | $1.345B | 126.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.112B | 0.00 |
| OPKO Health (OPK) | United States | $1.071B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.999B | 5.31 |
| Pulse Biosciences (PLSE) | United States | $0.990B | 0.00 |
| SiBone (SIBN) | United States | $0.759B | 0.00 |
| IRadimed (IRMD) | United States | $0.735B | 37.29 |
| Beta Bionics (BBNX) | United States | $0.636B | 0.00 |
| AxoGen (AXGN) | United States | $0.612B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.548B | 8.53 |
| OrthoPediatrics (KIDS) | United States | $0.541B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.505B | 10.86 |
| Pacific Biosciences Of California (PACB) | United States | $0.462B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.452B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.422B | 9.82 |
| Delcath Systems (DCTH) | United States | $0.380B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.371B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.352B | 0.00 |
| RxSight (RXST) | United States | $0.318B | 0.00 |
| Neuronetics (STIM) | United States | $0.296B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.295B | 0.00 |
| NeuroPace (NPCE) | United States | $0.288B | 0.00 |
| 908 Devices (MASS) | United States | $0.249B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.246B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.240B | 14.52 |
| CVRx (CVRX) | United States | $0.215B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.202B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.179B | 0.00 |
| Inogen (INGN) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.164B | 0.00 |
| LENSAR (LNSR) | United States | $0.154B | 0.00 |
| Accuray (ARAY) | United States | $0.154B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.121B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.119B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.117B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.115B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.097B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.088B | 53.30 |
| EnVVeno Medical (NVNO) | United States | $0.086B | 0.00 |
| Hyperfine (HYPR) | United States | $0.082B | 0.00 |
| InspireMD (NSPR) | United States | $0.075B | 0.00 |
| Spectral AI (MDAI) | United States | $0.064B | 0.00 |
| Positron (POSC) | United States | $0.060B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.055B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.054B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.052B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.022B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.013B | 0.00 | |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 14.94 |